We present 8-year follow-up on the first patient with stage 4 ameloblastoma carrying a BRAF V600E mutation treated with dual BRAF/MEK inhibition (BRAF/MEKi). He experienced a durable clinical response while on dabrafenib (BRAFi) and trametinib (MEKi) without toxicity nor evidence for drug-resistant tumor progression. He was asymptomatic when he self-discontinued therapy after 4 years of sustained clinical response. He did not return for follow-up until 2.5 years later with onset of painful mandibular tumor recurrence associated with recurrent bilateral lung metastases. He was rechallenged with dabrafenib/trametinib and experienced another prompt tumor response and remains in a second durable clinical remission (currently > 16 months) on continuous dual targeted therapy. We discuss the implications of this case study for future treatment strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.oraloncology.2022.105854 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Imaging findings in a case of primary intraosseous carcinoma arising from a mandibular cyst.
Oral Radiol
November 2024
, Fukuoka, Japan.
Primary intraosseous carcinoma not otherwise specified (PIOC NOS) is a rare tumor assumed to arise from the epithelium, such as odontogenic cysts or benign tumors. Its clinical and imaging diagnoses are often challenging, especially in the early stages, as it mimics jaw cysts and benign tumors, and no specific findings have been identified. This report presents the case of a 66-year-old male patient with mandibular PIOC, highlighting the imaging findings over time.
View Article and Find Full Text PDFJaw in a day surgery: early experience with 19 patients at an Australian tertiary referral center.
ANZ J Surg
September 2024
Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Background: The Jaw-in-a-Day (JIAD) procedure aims to achieve immediate functional occlusion via a single-stage approach to maxillofacial reconstruction. While JIAD has gained popularity since its inception by Levine and colleagues, efficacy and outcome data remain limited. In this report, we discuss our experience with the JIAD technique at an Australian tertiary referral centre.
View Article and Find Full Text PDFThe dental implant survival rate in 18 patients with post-operation revolutionary jaw reconstruction using free fibular flap, dental implants, and overdentures.
J Dent Sci
July 2024
Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Background/purpose: This retrospective study assessed the risks and complications associated with dental implants after jaw surgery and radiotherapy for large defects, highlighting challenges for reconstructive surgeons and prosthetic dentists.
Materials And Methods: From 2002 to 2008, National Taiwan University's Department of Maxillofacial Surgery used preoperative stereolithographic models and microvascular flaps for mandibular reconstruction in 18 patients with defects from ameloblastoma or advanced gingival cancer. They received free fibular flap grafts, followed by 46 osseointegrated dental implants.
A three-dimensional quantitative assessment on bony growth and symmetrical recovery of mandible after decompression for unicystic ameloblastoma.
Sci Rep
July 2024
Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, #79 Qingchun Road, Hangzhou, Zhejiang, China.
Unicystic ameloblastoma (UAM) of the jaw can be effectively reduced in volume through decompression, which promotes bone regeneration and restores jaw symmetry. This study quantitatively evaluated changes in mandible volume and symmetry following decompression of mandibular UAM. This study included 17 patients who underwent surgical decompression followed by second-stage curettage for mandibular UAM.
View Article and Find Full Text PDFAn Unusual Case Report of Unicystic Ameloblastoma of the Mandible.
J Pharm Bioallied Sci
February 2024
Department of Dental, Prince Sattam Bin Abdulaziz University Hospital, Al-Kharj, Saudi Arabia.
Article Synopsis
- Benign lesions can cause swelling in the mandible and are classified as either odontogenic or non-odontogenic, with ameloblastoma being the most common odontogenic lesion originating from dental tissues.
- Ameloblastoma is serious due to its prevalence, and it comprises different forms, including the solid multicystic type (80%) and the unicystic variant (20%), known as unicystic ameloblastoma (UA), which may mimic jaw cysts.
- UA lesions have a low likelihood of metastasis (5-15%) but tend to grow slowly and can be locally invasive with a high recurrence rate; careful diagnosis is essential to differentiate them from other similar unicystic lesions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!